The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.4149/bll_2018_076
|View full text |Cite
|
Sign up to set email alerts
|

The novel diagnostic marker in low-LVEF heart failure patients

Abstract: PIP may not mirror acute events in follow-up of chronic heart failure but it is a very beneficial biomarker in diagnosis of low-LVEF heart failure with high sensitivity and specificity (Tab. 2, Fig. 1, Ref. 16).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 13 publications
0
5
0
1
Order By: Relevance
“…PICP, a product in the metabolism of collagen type 1, was proven useful for the diagnosis and prognosis of heart failure and is associated with GLS values in patients with diabetes [28,29]. Moreover, on endomyocardial biopsy, PICP indicates the presence of collagen type I, adding to the hypothesis that this molecule can serve as a biomarker of cardiac fibrosis [30].…”
Section: Discussionmentioning
confidence: 99%
“…PICP, a product in the metabolism of collagen type 1, was proven useful for the diagnosis and prognosis of heart failure and is associated with GLS values in patients with diabetes [28,29]. Moreover, on endomyocardial biopsy, PICP indicates the presence of collagen type I, adding to the hypothesis that this molecule can serve as a biomarker of cardiac fibrosis [30].…”
Section: Discussionmentioning
confidence: 99%
“…We also have documented the BNP is associated with anxiety in heart failure patients and the LVEF was significantly and negatively related with HAM-A 14 score. As important reflectors of cardiac function, NYHA classification, BNP and LVEF are widely used factors in predicting the existence and severity of heart failure [ 33 35 ]. It was relatively easy to conceive that the anxiety status would significantly increase as the symptoms of heart failure were getting worse.…”
Section: Discussionmentioning
confidence: 99%
“…Thirdly, complications, such as impaired renal function, may differentially infl uence the levels of both biomarkers (24). Consequently, the use of sNEP, simultaneously to NT-proBNP as a gold standard biomarker in HF and as a default comparator, when investigating novel biomarkers and therapies (28)(29)(30), may be of diagnostic advantage providing an additional valuable prognostic information for identifying diverse HF patient subpopulations. However, less sNEP in HFrEF sheds a new light on this hypothesis.…”
Section: Discussionmentioning
confidence: 99%